We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$1.32M
(-0.13%)
Cap. Flow
-$27.2M
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
36.57%
Holding
447
New
77
Increased
110
Reduced
140
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinor
EQNR
|
+$9.87M |
| 2 |
Microsoft
MSFT
|
+$9.79M |
| 3 |
Zurn Elkay Water Solutions
ZWS
|
+$8.79M |
| 4 |
ERF
Enerplus Corporation
ERF
|
+$6.71M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$5.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$28.4M |
| 2 |
Antero Resources
AR
|
+$22.5M |
| 3 |
Imperial Oil
IMO
|
+$11.8M |
| 4 |
AbbVie
ABBV
|
+$9.22M |
| 5 |
Danaos Corp
DAC
|
+$8.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 35.09% |
| 2 | Technology | 13.02% |
| 3 | Healthcare | 11.46% |
| 4 | Industrials | 9.72% |
| 5 | Financials | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Xenon Pharmaceuticals
XENE
$6.32B
| $1.32M | 0.13% |
36,438
+1,438
| +4% | +$51.7K |
|
|
DNB
127
DELISTED
Dun & Bradstreet
DNB
| $1.29M | 0.13% |
103,775
+9,725
| +10% | +$144K |
|
128
Immunocore
IMCR
$1.78B
| $1.27M | 0.12% |
+27,171
| New | +$1.29M |
|
129
NuScale Power
SMR
$2.8B
| $1.25M | 0.12% |
106,864
-34,938
| -25% | -$459K |
|
130
ATI
ATI
$27B
| $1.25M | 0.12% |
46,868
+28,707
| +158% | +$799K |
|
|
STKL
131
DELISTED
SunOpta
STKL
| $1.21M | 0.12% |
+133,141
| New | +$1.26M |
|
132
Amazon
AMZN
$2.5T
| $1.21M | 0.12% |
10,693
+41
| +0.4% | +$5.18K |
|
133
iShares MSCI ACWI ETF
ACWI
$32.6B
| $1.2M | 0.12% |
15,470
+4,117
| +36% | +$356K |
|
134
Cytokinetics
CYTK
$11B
| $1.2M | 0.12% |
24,808
-12,075
| -33% | -$581K |
|
135
Sweetgreen
SG
$713M
| $1.2M | 0.12% |
64,720
+23,668
| +58% | +$403K |
|
136
Abbott
ABT
$180B
| $1.2M | 0.12% |
12,350
-65
| -0.5% | -$6.93K |
|
|
RUTH
137
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.19M | 0.12% |
70,290
-625
| -0.9% | -$11.1K |
|
138
Union Pacific
UNP
$183B
| $1.16M | 0.11% |
5,972
-32
| -0.5% | -$7.08K |
|
139
Mueller Industries
MLI
$14.1B
| $1.15M | 0.11% |
+77,564
| New | +$1.21M |
|
|
INTE
140
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
| $1.15M | 0.11% |
115,940
-35,240
| -23% | -$350K |
|
141
Oaktree Specialty Lending
OCSL
$1.03B
| $1.14M | 0.11% |
63,545
+905
| +1% | +$18.4K |
|
142
Visteon
VC
$2.77B
| $1.14M | 0.11% |
10,772
+2,820
| +35% | +$336K |
|
143
Harmonic Inc
HLIT
$1.21B
| $1.14M | 0.11% |
+86,851
| New | +$938K |
|
144
Sixth Street Specialty
TSLX
$1.59B
| $1.13M | 0.11% |
69,263
+5,205
| +8% | +$96.9K |
|
145
Fortune Brands Innovations
FBIN
$6.12B
| $1.13M | 0.11% |
24,544
-217
| -0.9% | -$11.8K |
|
146
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $1.12M | 0.11% |
30,809
| – | – |
|
147
FS KKR Capital
FSK
$2.98B
| $1.12M | 0.11% |
65,942
-814
| -1% | -$17K |
|
|
VTYX
148
DELISTED
Ventyx Biosciences
VTYX
| $1.11M | 0.11% |
+31,726
| New | +$702K |
|
149
DocGo
DCGO
$58.9M
| $1.11M | 0.11% |
+111,511
| New | +$1.01M |
|
150
GitLab
GTLB
$5.28B
| $1.1M | 0.11% |
21,450
+8,947
| +72% | +$522K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q3 2022 Portfolio in Review
As of Q3 2022, Advisory Research held 447 positions worth $1.02B, down 0.13% from $1.02B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Advisory Research's Q3 2022 filing shows 77 new, 110 increased, 140 reduced and 93 closed positions. Its largest new stake was Velo3D, Inc.: 38,954 shares worth $5.37M. The largest sale was Denbury Inc., an estimated $28.4M.
By sector, the portfolio is most concentrated in Energy at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.
- Advisory Research's largest Q3 2022 buy was Velo3D, Inc.: 38,954 shares worth $5.37M.
- Advisory Research added most to Equinor in Q3 2022, an estimated $9.87M increase.
- Advisory Research's biggest Q3 2022 reduction was Denbury Inc., cutting an estimated $28.4M.
- Advisory Research fully exited Imperial Oil in Q3 2022, selling an estimated $11.8M.
- Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q3 2022.
- Advisory Research opened 77 new positions and closed 93 in Q3 2022.
- Advisory Research's portfolio value fell 0.13% quarter-over-quarter to $1.02B.
Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.